Hormone-driven cancers, like those of the breast and prostate, often rely on a tricky-to-target protein called Forkhead box protein 1 (FOXA1). FOXA1 mutations can enable these types of cancers to grow and proliferate.
Grail pushed a more restrictive employee arbitration agreement shortly before lawsuits
The cancer-testing company Grail took steps last month to push more employee legal disputes into private arbitration, substantially revising a prior policy that left the